Johnson & Johnson (ETR:JNJ)
206.05
+0.15 (0.07%)
Mar 6, 2026, 1:12 PM CET
Johnson & Johnson Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2021 - 2017 |
| Revenue | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 | Upgrade
|
| Revenue Growth (YoY) | 6.05% | 4.30% | 6.46% | 1.59% | -4.66% | Upgrade
|
| Cost of Revenue | 30,065 | 27,036 | 26,244 | 24,596 | 23,402 | Upgrade
|
| Gross Profit | 64,128 | 61,785 | 58,915 | 55,394 | 55,338 | Upgrade
|
| Selling, General & Admin | 23,130 | 21,952 | 20,166 | 19,078 | 19,506 | Upgrade
|
| Research & Development | 14,665 | 17,232 | 15,085 | 14,135 | 14,277 | Upgrade
|
| Operating Expenses | 37,795 | 39,184 | 35,251 | 33,213 | 33,783 | Upgrade
|
| Operating Income | 26,333 | 22,601 | 23,664 | 22,181 | 21,555 | Upgrade
|
| Interest Expense | -971 | -755 | -772 | -276 | -183 | Upgrade
|
| Interest & Investment Income | 1,056 | 1,332 | 1,261 | 490 | 53 | Upgrade
|
| Currency Exchange Gain (Loss) | -254 | -214 | -366 | -286 | -216 | Upgrade
|
| Other Non Operating Income (Expenses) | 851 | 1,382 | -17,936 | -556 | -550 | Upgrade
|
| EBT Excluding Unusual Items | 27,015 | 24,346 | 5,851 | 21,553 | 20,659 | Upgrade
|
| Merger & Restructuring Charges | -812 | -1,469 | -798 | -575 | -209 | Upgrade
|
| Gain (Loss) on Sale of Investments | 400 | -300 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 263 | 226 | 117 | 380 | 617 | Upgrade
|
| Asset Writedown | -204 | -405 | -1,295 | -1,216 | -989 | Upgrade
|
| Legal Settlements | 6,000 | -5,500 | 11,500 | - | - | Upgrade
|
| Pretax Income | 32,581 | 16,687 | 15,062 | 19,359 | 19,178 | Upgrade
|
| Income Tax Expense | 5,777 | 2,621 | 1,736 | 2,989 | 1,377 | Upgrade
|
| Earnings From Continuing Operations | 26,804 | 14,066 | 13,326 | 16,370 | 17,801 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 21,827 | 1,571 | 3,077 | Upgrade
|
| Net Income | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | Upgrade
|
| Net Income to Common | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | Upgrade
|
| Net Income Growth | 90.56% | -59.99% | 95.94% | -14.07% | 41.89% | Upgrade
|
| Shares Outstanding (Basic) | 2,407 | 2,407 | 2,534 | 2,625 | 2,632 | Upgrade
|
| Shares Outstanding (Diluted) | 2,429 | 2,429 | 2,560 | 2,664 | 2,674 | Upgrade
|
| Shares Change (YoY) | - | -5.12% | -3.89% | -0.38% | 0.12% | Upgrade
|
| EPS (Basic) | 11.13 | 5.84 | 13.88 | 6.83 | 7.93 | Upgrade
|
| EPS (Diluted) | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 | Upgrade
|
| EPS Growth | 90.50% | -57.81% | 103.94% | -13.84% | 41.75% | Upgrade
|
| Free Cash Flow | 19,698 | 19,842 | 18,410 | 17,488 | 19,758 | Upgrade
|
| Free Cash Flow Per Share | 8.11 | 8.17 | 7.19 | 6.57 | 7.39 | Upgrade
|
| Dividend Per Share | 5.140 | 4.910 | 4.700 | 4.450 | 4.190 | Upgrade
|
| Dividend Growth | 4.68% | 4.47% | 5.62% | 6.21% | 5.28% | Upgrade
|
| Gross Margin | 68.08% | 69.56% | 69.18% | 69.25% | 70.28% | Upgrade
|
| Operating Margin | 27.96% | 25.45% | 27.79% | 27.73% | 27.38% | Upgrade
|
| Profit Margin | 28.46% | 15.84% | 41.28% | 22.43% | 26.52% | Upgrade
|
| Free Cash Flow Margin | 20.91% | 22.34% | 21.62% | 21.86% | 25.09% | Upgrade
|
| EBITDA | 33,836 | 29,940 | 30,767 | 28,510 | 28,206 | Upgrade
|
| EBITDA Margin | 35.92% | 33.71% | 36.13% | 35.64% | 35.82% | Upgrade
|
| D&A For EBITDA | 7,503 | 7,339 | 7,103 | 6,329 | 6,651 | Upgrade
|
| EBIT | 26,333 | 22,601 | 23,664 | 22,181 | 21,555 | Upgrade
|
| EBIT Margin | 27.96% | 25.45% | 27.79% | 27.73% | 27.38% | Upgrade
|
| Effective Tax Rate | 17.73% | 15.71% | 11.53% | 15.44% | 7.18% | Upgrade
|
| Advertising Expenses | 1,600 | 600 | 500 | 700 | 1,200 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.